Disulfide exchange in CD4

BioFactors

Volumn 17, Issue 1-4, 2003, Pages 241-248

  Matthias, Lisa J ^a   Yam, Patricia T W ^a   Jiang, Xing Mai ^a   Hogg, Philip J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DISULFIDE; THIOREDOXIN;

CELL LABELING; CELL SURFACE; CONFERENCE PAPER; DISULFIDE BOND; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0142075880     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520170123     Document Type: Conference Paper

References (33)

1. R. Noiva, Enzymatic catalysis of disulfide formation, Protein Expr. Purif. 5 (1994), 1-13.
2. C.N. Pace, G.R. Grimsley, J.A. Thomson and B.J. Barnett, Conformational stability and activity of ribonucelase T1 with zero, one, and two intact disulfide-bonds, J. Biol. Chem. 263 (1988), 11820-11825.
3. R. Wetzel, Harnessing disulfide-bonds using protein engineering, Trends Biochem. Sci. 12 (1987), 478-482.
4. S.J. Weiner, P.A. Kollman, D.A. Case, U.C. Singh, C. Ghio, G. Alagona, S. Jr. Profeta and P. Weiner, A new force field for molecular mechanical simulation of nucleic acids and proteins, J. Am. Chem. Soc. 106 (1984), 765-784.
5. B.A. Katz and A. Kossiakoff, The crystallographically determined structures of atypical strained disulfides engineered into subtilisin, J. Biol. Chem. 261 (1986), 15480-15485.
6. P.E. Pjura, M. Matsumura, J.A. Wozniak and B.W. Matthews, Structure of a thermostable disulfide-bridge mutant of phage T4 lysozyme shows that an engineered cross-link in a flexible region does not increase the rigidity of the folded protein, Biochemistry 29 (1990), 2592-2598.
7. J.A. Wells and D.B. Power, In vivo formation and stability of engineered disulfide-bonds in subtilisin, J. Biol. Chem. 261 (1986), 6564-6570.
8. J.M. Thornton, Disulphide bridges in globular proteins, J. Mol. Biol. 151 (1981), 261-287.
9. A.J. Lay, X.-M. Jiang, O. Kisker, E. Flynn, A. Underwood, R. Condron and P.J. Hogg, Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase, Nature 408 (2000), 869-873.
10. L. Xie, C.N. Chesterman and P.J. Hogg, Control of von Willebrand factor multimer size by thrombospondin-1, J. Exp. Med. 193 (2001), 1341-1349.
11. R.J. Harris, S.M. Chamow, T.J. Gregory and M.W. Spellman, Characterization of a soluble form of human CD4, Eur. J. Biochem. 188 (1990), 291-300.
12. J. Wang, Y. Yan, T.P.J. Garrett, J. Liu, D.W. Rodgers, R.L. Garlick, G.E. Tarr, Y. Husain, E.L. Reinherz and S.C. Harrison, Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains, Nature 348 (1990), 411-418.
13. S.R. Ryu, P.D. Kwong, A. Truneh, T.G. Porterm, J. Arthos, M. Rosenberg, X. Dai, N. Xuong, R. Axel, R.W. Sweet and W.A. Hendrickson, Crystal structure of an HIV-binding recombinant fragment of human CD4, Nature 348 (1990), 419-426.
14. R.L. Brady, E.J. Dodson, G. Lange, S.J. Davis, A.F. Williams and A.N. Barclay, Crystal structure of domains 3 and 4 of rat CD4: relation to the NH2-terminal domains, Science 260 (1993), 979-983.
15. N. Srinivasan, R. Sowdhamini, C. Ramakrishnan and P. Balaram, Conformation of disulfide bridges in proteins, Int. J. Peptide Protein Res. 36 (1990), 147-155.
16. I. Nakashima, M. Pu, A. Nishizaki, I. Rosila, L. Ma, Y. Katano, K. Ohkusu, S.M.J. Rahman, K. Isobe, M. Hamaguchi and K. Saga, Redox mechanism as alternative to ligand binding for receptor activation delivering disregulated cellular signals, J. Immunol. 152 (1994), 1064-1071.
17. G.W. Lynch, A.J. Sloane, V. Rasco, A. Lai and A.L. Cunningham, Direct evidence for native CD4 oligomers in lymphoid and monocytoid cells, Eur. J. Immunol. 29 (1999), 2590-2602.
18. H.J.-P. Ryser, E.M. Levy, R. Mandel and G.J. DiSciullo, Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction, Proc. Natl. Acad. Sci. USA 91 (1994), 45459-4563.
19. H.M. Ingalls, C.M. Goodloe-Holland and E.J. Luna, Junctional plasma membrane domains isolated from aggregating Dictyostelium discoideum amebae, Proc. Natl. Acad. Sci. USA 83 (1986), 4779-4783.
20. X.-M. Jiang, M. Fitzgerald, C.M. Grant and P.J. Hogg, Redox control of exofacial protein thiols/disulfides by protein disulfide isomerase, J. Biol. Chem. 274 (1999), 2416-2423.
21. K. Tonissen, J. Wells, I. Cock, A. Perkins, C. Orozco and F. Clarke, Site-directed mutagenesis of human thioredoxin, J. Biol. Chem. 268 (1993), 22485-22489.
22. K.C. Deen, J.S. McDougal, R. Inacker, G. Folena-Wasserman, J. Arthos, J. Rosenberg, P.J. Maddon, R. Axel, R.W. Sweet, A soluble form of CD4 (T4) protein inhibits AIDS virus infection, Nature 331 (1988), 82-84.
23. J.A. Richardson, Protein anatomy, Advan. Protein. Chem. 34 (1981), 167-339.
24. I.L. Karle, R. Kishore, S. Raghothama and P. Balaram, Cyclic cystine peptides. Antiparallel β-sheet conformation for the 20-membered ring in Boc-Cys-Val-Aib-Ala-Leu-Cys-NHMe, J. Am. Chem. Soc. 110 (1988), 1958-1963.
25. I.L. Karle, J.L. Flippen-Anderson, R. Kishore and P. Balaram, Cystine peptides, Int. J. Peptide Protein Res. 34 (1989), 37-41.
26. A.F. Williams, S.J. Davis, Q. He and A.N. Barclay, Structural diversity in domains of the immunoglobulin superfamily, Cold Spring Harbor Symp. Quant. Biol. 65 (1989), 637-647.
27. L. Kirszbaum, J.A. Sharpe, N. Goss, J. Lahnstein and I.D. Walker, The alpha-chain of murine CD8 lacks an invariant Ig-like disulfide-bond but contains a unique intrachain loop instead, J. Immunol. 142 (1989), 3931-3936.
28. A. Holmgren, Thioredoxin, Ann. Rev. Biochem. 54 (1985), 237-271.
29. Y. Tagaya, Y. Maeda, A. Mitsui, N. Kondo, H. Matsui, J. Hamuro, N. Brown, K. Arai, T. Yokota, H. Wakasugi and J. Yodoi, ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin: possible involvement of a dithiol-reduction in the IL-2 receptor induction, EMBO J. 8 (1989), 757-764.
30. H. Martin and M. Dean, Identification of a thioredoxin-related protein associated with plasma membranes, Biochem. Biophys. Res. Commun. 175 (1991), 123-128.
31. A. Rubartelli, A. Bajetto, G. Allavena, E. Wollman and R. Sitia, Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway, J. Biol. Chem. 267 (1992), 24161-24164.
32. E.E. Woolman, A. Kahan and D. Fradelizi, Detection of membrane associated thioredoxin on human cell lines, Biochem. Biophys. Res. Commun. 230 (1997), 602-606.
33. A. Soderberg, B. Sahaf and A. Rosen, Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma, Cancer Res. 60 (2000), 2281-2289.